Researchers from the QIMR Berghofer Medical Research Institute in Australia have described the development of a melanoma risk stratification tool based on self-reported patient information that is ...
The US FDA has granted De Novo marketing authorization for ArteraAI Prostate (Artera, Los Altos, California), a novel artificial intelligence (AI)-powered risk-stratification tool for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback